GTR 92217756
Bids Are Invited For The Object Of This Bidding Is The Choice Of The Most Advantageous Proposal For Installment Acquisition Of Antineoplastic And Cytostatic Drugs (5 Ml And Others), For Chc/Ufpr, According To Conditions, Quantities And Requirements Established In The Notice And Its Attachments
ICB — International Competitive Bid
Closed
South America
Tender Information
GTR Reference
92217756
Tendering Authority
Subscribe to view
Tender No
90005/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For The Object Of This Bidding Is The Choice Of The Most Advantageous Proposal For Installment Acquisition Of Antineoplastic And Cytostatic Drugs (5 Ml And Others), For Chc/Ufpr, According To Conditions, Quantities And Requirements Established In The Notice And Its Attachments
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
18-02-2025
Closed
Work Detail
The Object Of This Bidding Is The Choice Of The Most Advantageous Proposal For Installment Acquisition Of Antineoplastic And Cytostatic Drugs (5 Ml And Others), For Chc/Ufpr, According To Conditions, Quantities And Requirements Established In The Notice And Its Attachments. Ethoposide, Vimblastin, Vinchristine, Carmustine, Cyclophosphamide, Cyclophosphamide, Chlorambucil, Melphala, Mitoxanthrone Chloride, Citarabine, Mercaptopine, Tioguanin, Bleomycin, Daunorrubicin, Doxorrubicin Hydle Melfalana, Vinorelbine, Probiotic, Megestrol Acetate, Genoclytabine Hydrochloride , Fludarabine Phosphate, Anastrozole, Sodium Pamidronate, Capecitabine, Rituximab, Bicalutamide, Tretinoin, Citarabine, Metotrexate, Fluoruracil, Topotecan, Irinotecan Chloride, Cisplatin, Dochaliplain, Oxaliplate Ridrate, Idarrubicin Hydrochloride, Anagelida Hydrochloride, Tamoxifen Citrate, Dacarbazine, Bortezomibe, Paclitaxel, Bussulphane, Vinorelbine, Vinorelbine, Cladribine, Iphosphamide, Carboplatin, Leupro -Arprorine Acetate, Pegaspargase, Abiraterone Acetate, Gefitinib, Blinatumomab
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
ab463105-b6a1-4d7d-8e4c-c3bafd43045e.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.